Home LiteratureArticle Details
PMID: 10799590 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Epstein-barr virus nuclear antigen 3C activates the latent membrane protein 1 promoter in the presence of Epstein-Barr virus nuclear antigen 2 through sequences encompassing an spi-1/Spi-B binding site.

Journal of virology ·Vol. 74 ·No. 11 ·2000-06-00 ·Pages 5151-60

Zhao B, Sample CE

Abstract

The Epstein-Barr virus (EBV) nuclear antigen 3C (EBNA-3C) protein is a transcriptional regulator of viral and cellular genes that is essential for EBV-mediated immortalization of B lymphocytes in vitro. EBNA-3C can inhibit transcription through an association with the cellular DNA-binding protein Jkappa, a function shared by EBNA-3A and EBNA-3B. Here, we report a mechanism by which EBNA-3C can activate transcription from the EBV latent membrane protein 1 (LMP-1) promoter in conjunction with EBNA-2. Jkappa DNA-binding sites were not required for this activation, and a mutant EBNA-3C protein unable to bind Jkappa activated transcription as efficiently as wild-type EBNA-3C, indicating that EBNA-3C can regulate transcription through a mechanism that is independent of Jkappa. Furthermore, activation of the LMP-1 promoter is a unique function of EBNA-3C, not shared by EBNA-3A and EBNA-3B. The DNA element through which EBNA-3C activates the LMP-1 promoter includes a Spi-1/Spi-B binding site, previously characterized as an important EBNA-2 response element. Although this element has considerable homology to mouse immunoglobulin light chain promoter sequences to which the mouse homologue of Spi-1 binds with its dimerization partner IRF4, we demonstrate that the IRF4-like binding sites in the LMP-1 promoter do not play a role in EBNA-3C-mediated activation. Both EBNA-2 and EBNA-3C were required for transcription mediated through a 41-bp region of the LMP-1 promoter encompassing the Spi binding site. However, EBNA-3C had no effect on transcription mediated in conjunction with the EBNA-2 activation domain fused to the GAL4 DNA-binding domain, suggesting that it does not function as an adapter between EBNA-2 and the cellular transcriptional machinery. Like EBNA-2, EBNA-3C bound directly to both Spi-1 and Spi-B in vitro. This interaction was mediated by a region of EBNA-3C encompassing a likely basic leucine zipper (bZIP) domain and the ets domain of Spi-1 or Spi-B, reminiscent of interactions between bZIP and ets domains of other transcription factors that result in their targeting to DNA. There are many examples of regulation of the hematopoietic-specific Spi transcription factors through protein-protein interactions, and a similar regulation by EBNA-3C, in conjunction with EBNA-2, is likely to be an important and unique contribution of EBNA-3C to EBV-mediated immortalization.

MeSH Terms
Binding Sites Cell Line, Transformed DNA-Binding Proteins/metabolism Epstein-Barr Virus Nuclear Antigens/metabolism Herpesvirus 4, Human/metabolism Humans Promoter Regions, Genetic Proto-Oncogene Proteins/metabolism Response Elements Trans-Activators/metabolism Transcription Factors/metabolism Transcriptional Activation Tumor Cells, Cultured Viral Matrix Proteins/genetics
Chemicals
DNA-Binding Proteins EBV-associated membrane antigen, Epstein-Barr virus Epstein-Barr Virus Nuclear Antigens Proto-Oncogene Proteins Trans-Activators Transcription Factors Viral Matrix Proteins proto-oncogene protein Spi-1 SPIB protein, human
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Zhao B
Program in Viral Oncogenesis and Tumor Immunology, Department of Virology and Molecular Biology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA.
Sample C E
References (60)
60 references, click to expand
  1. The last seven transmembrane and carboxy-terminal cytoplasmic domains of Epstein-Barr virus latent membrane protein 2 (LMP2) are dispensable for lymphocyte infection and growth transformation in vitro.
    J Virol. 1993 Apr;67(4):2006-13 PMID: 8383224
  2. The amino-terminal domains of Epstein-Barr virus nuclear proteins 3A, 3B, and 3C interact with RBPJ(kappa).
    J Virol. 1996 May;70(5):3068-74 PMID: 8627785
  3. Effect of PU.1 phosphorylation on interaction with NF-EM5 and transcriptional activation.
    Science. 1993 Mar 12;259(5101):1622-5 PMID: 8456286
  4. Latent membrane protein of Epstein-Barr virus induces cellular phenotypes independently of expression of Bcl-2.
    J Virol. 1993 Sep;67(9):5269-78 PMID: 8394449
  5. Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation.
    Proc Natl Acad Sci U S A. 1993 Oct 1;90(19):9150-4 PMID: 8415670
  6. The Epstein-Barr virus immortalizing protein EBNA-2 is targeted to DNA by a cellular enhancer-binding protein.
    Proc Natl Acad Sci U S A. 1993 Oct 15;90(20):9237-41 PMID: 8415684
  7. Epstein-Barr virus nuclear antigen EBNA3C/6 expression maintains the level of latent membrane protein 1 in G1-arrested cells.
    J Virol. 1994 Jun;68(6):3491-8 PMID: 8189488
  8. Mediation of Epstein-Barr virus EBNA2 transactivation by recombination signal-binding protein J kappa.
    Science. 1994 Jul 1;265(5168):92-5 PMID: 8016657
  9. The Epstein-Barr virus nuclear antigen 2 transactivator is directed to response elements by the J kappa recombination signal binding protein.
    Proc Natl Acad Sci U S A. 1994 Aug 2;91(16):7568-72 PMID: 8052621
  10. Identification and characterization of an Epstein-Barr virus nuclear antigen 2-responsive cis element in the bidirectional promoter region of latent membrane protein and terminal protein 2 genes.
    J Virol. 1994 Nov;68(11):6947-58 PMID: 7933076
  11. The suppressor of hairless protein participates in notch receptor signaling.
    Cell. 1994 Oct 21;79(2):273-82 PMID: 7954795
  12. DNA-binding studies of the Epstein-Barr virus nuclear antigen 2 (EBNA-2): evidence for complex formation by latent membrane protein gene promoter-binding proteins in EBNA-2-positive cell lines.
    J Gen Virol. 1994 Nov;75 ( Pt 11):3067-79 PMID: 7964616
  13. Biochemical characterization of Epstein-Barr virus nuclear antigen 3A and 3C proteins.
    Virology. 1994 Dec;205(2):534-9 PMID: 7975254
  14. Epstein-Barr virus (EBV) nuclear antigen 6 induces expression of the EBV latent membrane protein and an activated phenotype in Raji cells.
    J Gen Virol. 1993 Mar;74 ( Pt 3):361-9 PMID: 8383171
  15. The Epstein-Barr virus determined nuclear antigens EBNA-3A, -3B, and -3C repress EBNA-2-mediated transactivation of the viral terminal protein 1 gene promoter.
    Virology. 1994 Dec;205(2):596-602 PMID: 7975264
  16. Epstein-Barr virus nuclear protein 2 transactivation of the latent membrane protein 1 promoter is mediated by J kappa and PU.1.
    J Virol. 1995 Jan;69(1):253-62 PMID: 7983717
  17. The Epstein-Barr virus nuclear protein 2 acidic domain can interact with TFIIB, TAF40, and RPA70 but not with TATA-binding protein.
    J Virol. 1995 Jan;69(1):585-8 PMID: 7983760
  18. The Spi-1/PU.1 and Spi-B ets family transcription factors and the recombination signal binding protein RBP-J kappa interact with an Epstein-Barr virus nuclear antigen 2 responsive cis-element.
    EMBO J. 1994 Dec 1;13(23):5624-32 PMID: 7988559
  19. Spi-1/PU.1: an oncogene of the Ets family.
    Biochim Biophys Acta. 1994 Dec 30;1198(2-3):149-63 PMID: 7819272
  20. The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family.
    Cell. 1995 Feb 10;80(3):389-99 PMID: 7859281
  21. Epstein-Barr virus nuclear protein 3C modulates transcription through interaction with the sequence-specific DNA-binding protein J kappa.
    J Virol. 1995 May;69(5):3108-16 PMID: 7707539
  22. The 62- and 80-kDa subunits of transcription factor IIH mediate the interaction with Epstein-Barr virus nuclear protein 2.
    Proc Natl Acad Sci U S A. 1995 Apr 11;92(8):3259-63 PMID: 7724549
  23. Functional interaction of c-Ets-1 and GHF-1/Pit-1 mediates Ras activation of pituitary-specific gene expression: mapping of the essential c-Ets-1 domain.
    Mol Cell Biol. 1995 May;15(5):2849-57 PMID: 7739565
  24. Epstein-Barr virus nuclear antigen 3C is a transcriptional regulator.
    J Virol. 1995 Jun;69(6):3624-30 PMID: 7745710
  25. Pip, a novel IRF family member, is a lymphoid-specific, PU.1-dependent transcriptional activator.
    Genes Dev. 1995 Jun 1;9(11):1377-87 PMID: 7797077
  26. Alterations in Notch signaling in neoplastic lesions of the human cervix.
    Proc Natl Acad Sci U S A. 1995 Jul 3;92(14):6414-8 PMID: 7604005
  27. Molecular cloning of LSIRF, a lymphoid-specific member of the interferon regulatory factor family that binds the interferon-stimulated response element (ISRE).
    Nucleic Acids Res. 1995 Jun 25;23(12):2127-36 PMID: 7541907
  28. A direct physical association between ETS and AP-1 transcription factors in normal human T cells.
    Immunity. 1995 Aug;3(2):223-37 PMID: 7648395
  29. The Epstein-Barr virus nuclear protein 2 acidic domain forms a complex with a novel cellular coactivator that can interact with TFIIE.
    Mol Cell Biol. 1995 Sep;15(9):4735-44 PMID: 7651391
  30. Multiple proteins physically interact with PU.1. Transcriptional synergy with NF-IL6 beta (C/EBP delta, CRP3).
    J Immunol. 1995 Nov 1;155(9):4330-8 PMID: 7594592
  31. Signalling downstream of activated mammalian Notch.
    Nature. 1995 Sep 28;377(6547):355-8 PMID: 7566092
  32. PU box-binding transcription factors and a POU domain protein cooperate in the Epstein-Barr virus (EBV) nuclear antigen 2-induced transactivation of the EBV latent membrane protein 1 promoter.
    J Gen Virol. 1995 Nov;76 ( Pt 11):2679-92 PMID: 7595375
  33. RBP-J kappa repression activity is mediated by a co-repressor and antagonized by the Epstein-Barr virus transcription factor EBNA2.
    Nucleic Acids Res. 1995 Dec 25;23(24):4939-45 PMID: 8559649
  34. MafB is an interaction partner and repressor of Ets-1 that inhibits erythroid differentiation.
    Cell. 1996 Apr 5;85(1):49-60 PMID: 8620536
  35. A conserved domain of the Epstein-Barr virus nuclear antigens 3A and 3C binds to a discrete domain of Jkappa.
    J Virol. 1996 Jul;70(7):4228-36 PMID: 8676443
  36. Epstein-Barr virus EBNA3A and EBNA3C proteins both repress RBP-J kappa-EBNA2-activated transcription by inhibiting the binding of RBP-J kappa to DNA.
    J Virol. 1996 Sep;70(9):5909-15 PMID: 8709211
  37. Pax-5 (BSAP) recruits Ets proto-oncogene family proteins to form functional ternary complexes on a B-cell-specific promoter.
    Genes Dev. 1996 Sep 1;10(17):2198-211 PMID: 8804314
  38. Cytostatic effect of Epstein-Barr virus latent membrane protein-1 analyzed using tetracycline-regulated expression in B cell lines.
    Virology. 1996 Sep 1;223(1):29-40 PMID: 8806537
  39. Pip, a lymphoid-restricted IRF, contains a regulatory domain that is important for autoinhibition and ternary complex formation with the Ets factor PU.1.
    Genes Dev. 1996 Sep 15;10(18):2335-47 PMID: 8824592
  40. Expression of the Epstein-Barr virus nuclear protein 2 in rodent cells.
    J Virol. 1986 Aug;59(2):453-62 PMID: 2426468
  41. Spi-1 is a putative oncogene in virally induced murine erythroleukaemias.
    Nature. 1988 Jan 21;331(6153):277-80 PMID: 2827041
  42. Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes.
    Nature. 1989 Aug 3;340(6232):393-7 PMID: 2547164
  43. Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation.
    Proc Natl Acad Sci U S A. 1989 Dec;86(23):9558-62 PMID: 2556717
  44. Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23.
    J Virol. 1990 May;64(5):2309-18 PMID: 2157887
  45. Epstein-Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B, and EBNA-3C genes.
    J Virol. 1990 Sep;64(9):4084-92 PMID: 2166806
  46. Recombinant Epstein-Barr virus with small RNA (EBER) genes deleted transforms lymphocytes and replicates in vitro.
    Proc Natl Acad Sci U S A. 1991 Feb 15;88(4):1546-50 PMID: 1847527
  47. Epstein-Barr virus nuclear protein 2 mutations define essential domains for transformation and transactivation.
    J Virol. 1991 May;65(5):2545-54 PMID: 1850028
  48. TAN-1, the human homolog of the Drosophila notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms.
    Cell. 1991 Aug 23;66(4):649-61 PMID: 1831692
  49. An Epstein-Barr virus nuclear protein 2 domain essential for transformation is a direct transcriptional activator.
    J Virol. 1991 Nov;65(11):5880-5 PMID: 1656076
  50. The Epstein-Barr virus nuclear protein encoded by the leader of the EBNA RNAs is important in B-lymphocyte transformation.
    J Virol. 1991 Dec;65(12):6826-37 PMID: 1658376
  51. PU.1 recruits a second nuclear factor to a site important for immunoglobulin kappa 3' enhancer activity.
    Mol Cell Biol. 1992 Jan;12(1):368-78 PMID: 1729611
  52. Characterization of Spi-B, a transcription factor related to the putative oncoprotein Spi-1/PU.1.
    Mol Cell Biol. 1992 Oct;12(10):4297-304 PMID: 1406622
  53. Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities.
    EMBO J. 1996 Oct 15;15(20):5647-58 PMID: 8896458
  54. Physical interactions between Ets and NF-kappaB/NFAT proteins play an important role in their cooperative activation of the human immunodeficiency virus enhancer in T cells.
    J Virol. 1997 May;71(5):3563-73 PMID: 9094628
  55. The role of Ets transcription factors in the development and function of the mammalian immune system.
    Adv Immunol. 1997;64:65-104 PMID: 9100980
  56. ETS1, NFkappaB and AP1 synergistically transactivate the human GM-CSF promoter.
    Oncogene. 1997 Jun 12;14(23):2845-55 PMID: 9190901
  57. Epstein-Barr virus nuclear protein LP stimulates EBNA-2 acidic domain-mediated transcriptional activation.
    J Virol. 1997 Sep;71(9):6611-8 PMID: 9261383
  58. Epstein-Barr virus leader protein enhances EBNA-2-mediated transactivation of latent membrane protein 1 expression: a role for the W1W2 repeat domain.
    J Virol. 1997 Sep;71(9):6619-28 PMID: 9261384
  59. Defective B cell receptor-mediated responses in mice lacking the Ets protein, Spi-B.
    EMBO J. 1997 Dec 1;16(23):7118-29 PMID: 9384589
  60. Epstein-Barr virus nuclear proteins EBNA-3A and EBNA-3C are essential for B-lymphocyte growth transformation.
    J Virol. 1993 Apr;67(4):2014-25 PMID: 8445720
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
2000-06-00
Pages
5151-60
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC110868
Subset
IM
Grants
NCI NIH HHS · CA-56645 · United States
NCI NIH HHS · CA-21765 · United States
NCI NIH HHS · R01 CA056645 · United States
NCI NIH HHS · P30 CA021765 · United States
NCI NIH HHS · CA73561 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]